Business Trends– category –
-
Sana Biotechnology Targets 2026 IND for iPSC-Derived Hypoimmune Pancreatic Islet Cell Therapy SC451 in Type 1 Diabetes
TipRanks / Sana Biotechnology, Inc. USA Overview Sana Biotechnology updated its investor presentation, emphasizing pipeline advancements, particularly for SC451, an iPSC-derived hypoimmune pancreatic islet cell therapy for Type 1 diabete... -
Cellipont Bioservices Supports Six Cell Therapy Programs Towards 2026 IND Filings, Highlighting CDMO Market Growth
Cellipont Bioservices (via Contract Pharma news) USA Overview Texas-based cell therapy CDMO Cellipont Bioservices announced it is supporting six client projects anticipated to reach Investigational New Drug (IND) submission in 2026. Thei... -
Fate Therapeutics to Detail iPSC-Derived Cellular Immunotherapy Pipeline at Cantor Global Healthcare Conference
Fate Therapeutics Press Releases / Barchart.com USA Overview Fate Therapeutics announced its management will participate in a fireside chat at the Cantor Global Healthcare Conference in New York, September 9-12, 2026. The company plans t... -
CRISPR Therapeutics to Detail Pipeline Progress at Morgan Stanley Global Healthcare Conference
CRISPR Therapeutics Press Releases USA Overview CRISPR Therapeutics announced its management will participate in the Morgan Stanley 24th Global Healthcare Conference on September 10, 2026. This engagement provides a critical platform for... -
IV Exosome Therapy: Under Investigation for Cell Behavior Modulation and Anti-Inflammation, FDA Not Yet Approved
Sanger Wellness Center USA Overview Exosomes, tiny extracellular vesicles involved in intercellular communication, are being investigated for their potential to influence cell behavior, inflammatory pathways, tissue response, and recover... -
Harro Höfliger’s Robust Database Optimizes Product Development, Resolving Regenerative Medicine Manufacturing Bottlenecks
Cell and Gene Germany Overview Harro Höfliger introduced a method for characterizing and optimizing product development in regenerative medicine manufacturing, leveraging a robust database. Integrated with a hierarchical automation platf... -
Parkinson’s Regenerative Medicine Milestone: iPSC-Derived Dopamine Precursors Safely Transplanted in First-in-Human Trial
Parkinson's NSW Sweden Overview A pivotal clinical trial led by Lund University has confirmed the safety and feasibility of transplanting iPSC-derived dopamine precursor cells into Parkinson's disease patients. Published in Nature Medici... -
CRISPR Gene Editing: Engineering Durable Cures for Congenital Diseases through Stem Cell and Liver Targeting
Liv Hospital Turkey Overview CRISPR gene editing technology promises a revolutionary approach to fundamentally cure congenital diseases by precisely correcting underlying genetic errors. By targeting the liver and hematopoietic stem cell... -
Comprehensive Analysis Reveals iPSC Potential in CAR-T Therapy for Cancer, Highlights Key Challenges
Research Journal of Pharmacy and Technology India Overview A comprehensive review analyzes the therapeutic potential and inherent risks of hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells... -
NVIDIA Partners with Australian Data Center Ecosystem to Expand AI Infrastructure Capacity by 2 GW by 2027
GLOBE NEWSWIRE Australia Overview NVIDIA announced a partnership with Australian cloud partners and AI infrastructure providers, including Firmus, Sharon AI, IREN, ResetData, Megaport, CDC, NEXTDC, and AirTrunk, to significantly expand A...
